Elite Pharmaceuticals Inc (ELTP)

[Couch]

In the end it always comes down to the bottom line: The Almighty Dollar. And the Almighty Dollar says that ADT opioids is going to save money and lives. So YES Elite's ADT opioids will be approved and nothing anybody is going to do to stop that.

Abuse-Deterrent Opioids Are Worth The Cost

http://www.forbes.com/sites/econostats/2015/03/13/abuse-deterrent-opioids-are-worth-the-cost-2/2/

A study that examined the impact from an abuse-deterrent formulation found that it reduced abuse of opioids by 18 percent among Medicaid patients and 23 percent for commercially insured patients. In total, such a reduction in opioid abuse creates $1 billion in benefits – the benefits being a reduction in the higher health care costs, lower workplace productivity, and higher criminal justice costs that are associated with opioid abuse.

The EconoSTATS study then compared these benefits against the current higher price of abuse-deterrent opioids. The study compared the costs and benefits on a per patient basis. On a per patient basis, and adjusting for abuse reductions associated with the drug, the total annual benefits created by abuse-deterrent opioids are around $4,600. Patented opioids only cost between $600 and $2,800 more than generic versions annually, depending upon the assumptions used.


Therefore, the use of abuse-deterrent opioids creates annual net benefits (benefits minus the additional costs) of between $1,800 and $4,000.